Summit Financial Wealth Advisors’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,155
Closed -$333K 196
2025
Q3
$333K Hold
7,155
0.05% 128
2025
Q2
$382K Hold
7,155
0.07% 111
2025
Q1
$290K Hold
7,155
0.06% 118
2024
Q4
$385K Hold
7,155
0.08% 104
2024
Q3
$205K Buy
+7,155
New +$187K 0.04% 145

Other funds holding AKRO